Cargando…

The cost-effectiveness challenge: is it worth it?

Scarcity of resources means that difficult choices have to be made about how to use them. Cost-effectiveness evidence provides a way to help decision-makers get ‘best value’ from their resources when choosing between two or more clinical or other interventions. Often it is found that one interventio...

Descripción completa

Detalles Bibliográficos
Autor principal: Knapp, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571137/
https://www.ncbi.nlm.nih.gov/pubmed/27391601
http://dx.doi.org/10.1186/s13195-015-0095-4
_version_ 1782390309831835648
author Knapp, Martin
author_facet Knapp, Martin
author_sort Knapp, Martin
collection PubMed
description Scarcity of resources means that difficult choices have to be made about how to use them. Cost-effectiveness evidence provides a way to help decision-makers get ‘best value’ from their resources when choosing between two or more clinical or other interventions. Often it is found that one intervention has better outcomes than another, but also costs more. In these circumstances there is a need for the decision-maker to reach a view as to whether those better outcomes are ‘worth’ the higher costs, necessitating difficult trade-offs. Illustrations from the dementia field are given to illustrate how these trade-offs might be made. For strategic decisions it has often proved helpful to use a generic outcome measure such as the quality-adjusted life year. The fundamental aim of a healthcare system is not to save money, but to save and improve lives. Cost-effectiveness and similar analyses can help by showing how to get the most out of available resources.
format Online
Article
Text
id pubmed-4571137
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45711372015-09-17 The cost-effectiveness challenge: is it worth it? Knapp, Martin Alzheimers Res Ther Commentary Scarcity of resources means that difficult choices have to be made about how to use them. Cost-effectiveness evidence provides a way to help decision-makers get ‘best value’ from their resources when choosing between two or more clinical or other interventions. Often it is found that one intervention has better outcomes than another, but also costs more. In these circumstances there is a need for the decision-maker to reach a view as to whether those better outcomes are ‘worth’ the higher costs, necessitating difficult trade-offs. Illustrations from the dementia field are given to illustrate how these trade-offs might be made. For strategic decisions it has often proved helpful to use a generic outcome measure such as the quality-adjusted life year. The fundamental aim of a healthcare system is not to save money, but to save and improve lives. Cost-effectiveness and similar analyses can help by showing how to get the most out of available resources. BioMed Central 2015-01-27 /pmc/articles/PMC4571137/ /pubmed/27391601 http://dx.doi.org/10.1186/s13195-015-0095-4 Text en © Knapp; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Knapp, Martin
The cost-effectiveness challenge: is it worth it?
title The cost-effectiveness challenge: is it worth it?
title_full The cost-effectiveness challenge: is it worth it?
title_fullStr The cost-effectiveness challenge: is it worth it?
title_full_unstemmed The cost-effectiveness challenge: is it worth it?
title_short The cost-effectiveness challenge: is it worth it?
title_sort cost-effectiveness challenge: is it worth it?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571137/
https://www.ncbi.nlm.nih.gov/pubmed/27391601
http://dx.doi.org/10.1186/s13195-015-0095-4
work_keys_str_mv AT knappmartin thecosteffectivenesschallengeisitworthit
AT knappmartin costeffectivenesschallengeisitworthit